Nanosilver supported on inert nano-diamond as a direct plasmonic photocatalyst for degradation of methyl blue

Wang, Zhimin; Zhang, Fengjiao; Ning, Aimin; Lv, Dongcan; Jiang, Guangce; Song, Andong

doi:10.1016/j.jece.2020.104912

Cited by 7 publications

(2 citation statements)

References 57 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Not only biological, but novel inorganic NPs like nano-diamond (Wang et al 2021d ) and graphene (Mariadoss et al 2020 ) have also attracted a significant attention of the researchers in cancer therapy. Innovation in nanotechnologies is a continuous process.…”

Section: Nanoparticles In Inflammationmentioning

confidence: 99%

Nanomedicines: intervention in inflammatory pathways of cancer

Anwar

Naqvi

Shams³

et al. 2023

Inflammopharmacol

View full text Add to dashboard Cite

Inflammation is a complex defense process that maintains tissue homeostasis. However, this complex cascade, if lasts long, may contribute to pathogenesis of several diseases. Chronic inflammation has been exhaustively studied in the last few decades, for its contribution in development and progression of cancer. The intrinsic limitations of conventional anti-inflammatory and anti-cancer therapies triggered the development of nanomedicines for more effective and safer therapies. Targeting inflammation and tumor cells by nanoparticles, encapsulated with active therapeutic agents, offers a promising outcome with patient survival. Considerable technological success has been achieved in this field through exploitation of tumor microenvironment, and recognition of molecules overexpressed on endothelial cells or macrophages, through enhanced vascular permeability, or by rendering biomimetic approach to nanoparticles. This review focusses on the inflammatory pathways in progression of a tumor, and advancement in nanotechnologies targeting these pathways. We also aim to identify the gaps that hinder the successful clinical translation of nanotherapeutics with further clinical studies that will allow oncologist to precisely identify the patients who may be benefited from nanotherapy at time when promotion or progression of tumor initiates. It is postulated that the nanomedicines, in near future, will shift the paradigm of cancer treatment and improve patient survival. Graphical abstract

show abstract

Section: Nanoparticles In Inflammationmentioning

confidence: 99%

Nanomedicines: intervention in inflammatory pathways of cancer

Anwar

Naqvi

Shams³

et al. 2023

Inflammopharmacol

View full text Add to dashboard Cite

show abstract

“…Recyclability, easy handling and the simple work-up nature make heterogeneous catalysts more advantageous than homogeneous catalysts. [16][17][18] For example, the Hibiscus tiliaceus L. extract mediated Pd/Fe 3 O 4 nanocomposite was used as a heterogeneous catalyst in the reduction of Cr(VI) and nitro compounds, 19 the GO/Fe 3 O 4 /Pd nanocomposite showed efficient heterogeneous catalytic property in the degradation of 4-nitrophenol (4-NP), Methyl Orange (MO), Methylene blue (MB) and Congo red (CR), 20 and Euphorbia maculate extract assisted Ni@Fe 3 O 4 and CuO nanoparticles degraded CR, MB and Rhodamine B (RhB) in a heterogeneous catalytic manner. 21 Photocatalytic activity is more prominent in the case of biocomposite nanoparticles than in single nanoparticles.…”

Section: Introductionmentioning

confidence: 99%